MedTrace Logo

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side

NCT06968637 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of diabetes alongside feedback on positive eye exams for DR can improve diabetes care outcomes.

The main questions it aims to answer are:

1. Does delivery of specific diabetes management recommendations to diabetes doctors for patients of theirs found to have DR lead to significantly improved blood glucose control as indicated by % reaching WHO targets of HbA1c (or targets for blood sugar if HbA1c data are unavailable)?
2. What is the cost-effectiveness of the intervention, measured as total intervention cost per additional participant reaching the WHO target?

Researchers will compare participant adherence with international guidelines when DR results are provided by a PIS without specific care recommendations to when the PIS provides DR results with specific care recommendations for DM management.

Conditions

Interventions

OTHER

care recommendations

Provision of specific care recommendations for diabetes management. Based on existing guidelines, when any DR is present, the PIS will prompt diabetologists to check, and if necessary, change medicines to optimize, blood sugar, blood pressure and lipids.

Sponsors & Collaborators

  • District Diabetes Hospital, Dinajpur district of Bangladesh

    collaborator UNKNOWN

  • Gausul Azam BNSB Eye Hospital in the Dinajpur district of Bangladesh

    collaborator UNKNOWN

  • Orbis

    lead OTHER

Principal Investigators

  • Munir Ahmed · Orbis Bangladesh

  • Nathan Congdon · Orbis

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Bangladesh

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968637 on ClinicalTrials.gov